These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31797842)
1. Expression of Yes-associated Protein in Oral Squamous Cell Carcinoma. Shelke P; Sarode GS; Sarode SC; Maniyar N; Prajapati G; Patil S J Contemp Dent Pract; 2019 Aug; 20(8):887-892. PubMed ID: 31797842 [TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma. Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796 [TBL] [Abstract][Full Text] [Related]
3. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456 [TBL] [Abstract][Full Text] [Related]
4. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma. Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587 [TBL] [Abstract][Full Text] [Related]
5. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer. Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520 [TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. Zhang L; Ye DX; Pan HY; Wei KJ; Wang LZ; Wang XD; Shen GF; Zhang ZY Oral Oncol; 2011 Aug; 47(8):693-7. PubMed ID: 21708480 [TBL] [Abstract][Full Text] [Related]
8. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck. Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431 [TBL] [Abstract][Full Text] [Related]
9. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia]. Zhang J; Zeng Y; Zheng J; Xu J Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728 [TBL] [Abstract][Full Text] [Related]
10. The role of YAP in the control of the metastatic potential of oral cancer. Ahmad US; Saravanan K; Wan H Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649 [TBL] [Abstract][Full Text] [Related]
11. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma. Moeckelmann N; Ebrahimi A; Tou YK; Gupta R; Low TH; Ashford B; Ch'ng S; Palme CE; Clark JR Oral Oncol; 2018 Oct; 85():82-86. PubMed ID: 30220324 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma. Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076 [TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma]. Tu MS; Li YS; Zhang X Shanghai Kou Qiang Yi Xue; 2018 Aug; 27(4):415-418. PubMed ID: 30483712 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells. Chu PC; Dokla EME; Hu JL; Weng JR Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453 [TBL] [Abstract][Full Text] [Related]
17. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC. Chen X; Gu W; Wang Q; Fu X; Wang Y; Xu X; Wen Y Oncotarget; 2018 Jan; 9(1):668-679. PubMed ID: 29416644 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Broder's and Bryne's Grading System for Oral Squamous Cell Carcinoma With Lymph Node Metastases and Prognosis: A Scoping Review. Thamilselvan S; Pandiar D; Krishnan RP; Ramalingam K; Pavithran P Cureus; 2024 Jan; 16(1):e51713. PubMed ID: 38313967 [TBL] [Abstract][Full Text] [Related]
19. To evaluate an association between prognostic significance of Moesin with histopathological grading of oral squamous cell carcinoma: A systematic review. Bommanavar S; Kanetkar SR; Datkhile KD J Oral Maxillofac Pathol; 2023; 27(1):148-161. PubMed ID: 37234334 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma. Oh KY; Hong KO; Huh YS; Lee JI; Hong SD J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]